Supported by scientific data and widely accepted by healthcare professionals

No adverse events or safety issues have been seen in 16 clinical studies for safety, even at 10 times the recommended dose. AmealPeptide^® has been shown to have:

• No negative effect on normal blood pressure

• No negative effect on people with lactose intolerance or milk allergies

Additionally, AmealPeptide^® is self-affirmed in 20 GRAS (Generally Recognized As Safe) categories presented to the FDA. It has also received a FOSHU (Foods For Specified Health Use) designation from the Japanese Ministry of Health, Labour and Welfare.